Why the study?
Does a strategy of rate control rather than complete pharmacologic suppression lead to safe recovery in pediatric patients with primary ventricular tachycardia?
Does a strategy of rate control rather than complete pharmacologic suppression lead to safe recovery in pediatric patients with primary ventricular tachycardia?
Primary ventricular tachycardia in children may be a self-limited condition where controlling the rate to an asymptomatic level is safer than attempting complete pharmacologic suppression.
Answers are grounded in this paper and cite their sources.
May support rate control over suppression in pediatric primary VT; hypothesis-generating and requires prospective trials before practice change.
Five male pediatric patients with primary ventricular tachycardia are described. Although three were initially in congestive heart failure due to the tachycardia and were extremely difficult to manage, all have completely recovered, are not taking medication, and are free of arrhythmia. Three of the patients required long-term management with quinidine, with a therapeutic goal of controlling the heart rather than abolishing the arrhythmia. No growth disturbances were found in those three patients. A review of reported cases revealed 71 infants and children with ventricular tachycardia not associated with heart disease or systemic disorders; only four deaths were reported (5.6%). In the primary form of ventricular tachycardia in children, complete pharmacologic suppression may not be achieved without seriously endangering the normal electrophysiologic functions. Controlling the rate to an asymptomatic level with pharmacologic means is safer for a problem that may be self-limited.
No takes yet. Share an insight, caveat, or question.
Bergdahl et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: